Catalyst Wire Dossier Catalyst Wire Dossier

EBV-TCR-T Cells

EBV-specific T-cell receptor-engineered T cells · Chinese PLA General Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBV-TCR-T Cells, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT [Phase 1]

See pricing